$60,000 of NOVO NORDISK INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of Inflation Reduction Act. Pharmacy Benefit Manager Reform, Health care supply chain. 340B. Treat and Reduce Obesity Act."
You can find more data on corporate lobbying on Quiver Quantitative.
NVO Congressional Stock Trading
Members of Congress have traded $NVO stock 10 times in the past 6 months. Of those trades, 7 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NVO stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $65,000 on 08/28, 08/19 and 0 sales.
- REPRESENTATIVE SCOTT FRANKLIN has traded it 4 times. They made 4 purchases worth up to $95,000 on 08/04 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 06/09 and 2 sales worth up to $30,000 on 08/04, 07/10.
- REPRESENTATIVE LAUREL M. LEE sold up to $15,000 on 05/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NVO Hedge Fund Activity
We have seen 677 institutional investors add shares of NVO stock to their portfolio, and 735 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 10,001,898 shares (+301443.6%) to their portfolio in Q2 2025, for an estimated $690,330,999
- AMUNDI removed 4,938,507 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $340,855,753
- FMR LLC added 4,308,228 shares (+44.7%) to their portfolio in Q2 2025, for an estimated $297,353,896
- TWO SIGMA ADVISERS, LP removed 3,465,100 shares (-71.3%) from their portfolio in Q2 2025, for an estimated $239,161,202
- NUVEEN, LLC removed 3,236,504 shares (-60.7%) from their portfolio in Q2 2025, for an estimated $223,383,506
- D. E. SHAW & CO., INC. removed 2,582,572 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $178,249,119
- JPMORGAN CHASE & CO removed 2,169,545 shares (-39.5%) from their portfolio in Q2 2025, for an estimated $149,741,995
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NVO Analyst Ratings
Wall Street analysts have issued reports on $NVO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 10/02/2025
- Morgan Stanley issued a "Underweight" rating on 09/29/2025
- Berenberg issued a "Buy" rating on 09/17/2025
- TD Cowen issued a "Buy" rating on 08/19/2025
To track analyst ratings and price targets for NVO, check out Quiver Quantitative's $NVO forecast page.
NVO Price Targets
Multiple analysts have issued price targets for $NVO recently. We have seen 4 analysts offer price targets for $NVO in the last 6 months, with a median target of $67.0.
Here are some recent targets:
- Rajesh Kumar from HSBC set a target price of $70.0 on 10/02/2025
- Thibault Boutherin from Morgan Stanley set a target price of $47.0 on 09/29/2025
- Michael Nedelcovych from TD Cowen set a target price of $70.0 on 08/19/2025
- Evan David Seigerman from BMO Capital set a target price of $64.0 on 04/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
